<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04381767</url>
  </required_header>
  <id_info>
    <org_study_id>EYESYNCCCV2020</org_study_id>
    <nct_id>NCT04381767</nct_id>
  </id_info>
  <brief_title>EYE-SYNC Concussion Classification Study</brief_title>
  <official_title>EYE-SYNC Concussion Classification Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sync-Think, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sync-Think, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the sensitivity and specificity of an aid in
      assessment of concussion based on eye-tracking, in comparison to a clinical reference
      standard appropriate for sport-related concussion evaluation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 19, 2018</start_date>
  <completion_date type="Actual">June 23, 2020</completion_date>
  <primary_completion_date type="Actual">March 23, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>A change in metrics of eye movement that enable positive concussion detection using EYE-SYNC metrics</measure>
    <time_frame>3 days</time_frame>
    <description>A True Positive and True Negative rate for identifying Concussion as compared to a Clinical Reference standard.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1303</enrollment>
  <condition>Concussion, Mild</condition>
  <condition>Concussion; Eye</condition>
  <condition>Concussion, Brain</condition>
  <condition>Concussion, Severe</condition>
  <condition>Brain Injuries</condition>
  <condition>Concussion, Cerebral</condition>
  <arm_group>
    <arm_group_label>Concussion Evaluation</arm_group_label>
    <description>Adult athletes receiving a clinical evaluation for a suspected concussion after head injury</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EYE-SYNC</intervention_name>
    <description>Evaluation of oculomotor performance using visual presentation and eye tracking analysis</description>
    <arm_group_label>Concussion Evaluation</arm_group_label>
    <other_name>SCAT-5</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will include all patients evaluated for potential traumatic brain injury
        presenting to the sports medicine clinicians in an athletic environment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women actively engaged in competitive athletics

          -  Eye tracking measurements and SCAT5 evaluations are collected within 3-day window

          -  Eye tracking measurements and SCAT5 evaluations are collected within 3 days of injury

        Exclusion Criteria:

          -  Prior enrollment (subjects may only enroll once)

          -  POOR eye tracking data quality

          -  Subjects without reported injury detailing alteration of consciousness (AOC) or
             altered mental status (AMS) defined as self-report, witness report or the following
             responses to the SCAT5 SSS: &quot;Difficulty Remembering&quot; ≥ 4 or &quot;Confusion&quot; ≥ 4, or scored
             less than 23 on the SCAT5 Standardized Assessment of Concussion (SAC) or greater than
             25 on the SCAT5 Symptom Severity Score (SSS)

          -  EYE-SYNC smooth pursuit standard deviation of tangential error (SDTE) variance scores
             &lt; 2.0
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sync-Think, Inc.</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 6, 2020</study_first_submitted>
  <study_first_submitted_qc>May 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2020</study_first_posted>
  <last_update_submitted>June 23, 2020</last_update_submitted>
  <last_update_submitted_qc>June 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

